153 related articles for article (PubMed ID: 35093716)
1. Establishment and characterization of human induced pluripotent stem cell line from a Parkinson's disease patient harboring VPS13A gene mutation.
Lu X; Wang W; Liu Y; Song N; Li M; Mu X; Zhang N; Chen Q; Jiang L; Kong X; Sun P; Tong J; Zhang Y; Li J; Ma S; Han F
Stem Cell Res; 2022 Apr; 60():102685. PubMed ID: 35093716
[TBL] [Abstract][Full Text] [Related]
2. Generation of induced pluripotent stem cell line (ZZUi007-A) from a 52-year-old patient with a novel CHCHD2 gene mutation in Parkinson's disease.
Wang Y; Wang Z; Sun H; Mao C; Yang J; Liu Y; Liu H; Zhang S; Zhang J; Xu Y; Shi C
Stem Cell Res; 2018 Oct; 32():87-90. PubMed ID: 30237140
[TBL] [Abstract][Full Text] [Related]
3. Generation and characterization of a genetic Parkinson's disease-patient derived iPSC line DJ-1-delP (LCSBi008-A).
Mencke P; Boussaad I; Önal G; Kievit AJA; Boon AJW; Mandemakers W; Bonifati V; Krüger R
Stem Cell Res; 2022 Jul; 62():102792. PubMed ID: 35500378
[TBL] [Abstract][Full Text] [Related]
4. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D
Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744
[TBL] [Abstract][Full Text] [Related]
5. Generation of an induced pluripotent stem cell line (CSC-44) from a Parkinson's disease patient carrying a compound heterozygous mutation (c.823C>T and EX6 del) in the PARK2 gene.
Marote A; Pomeshchik Y; Goldwurm S; Collin A; Lamas NJ; Pinto L; Salgado AJ; Roybon L
Stem Cell Res; 2018 Mar; 27():90-94. PubMed ID: 29353703
[TBL] [Abstract][Full Text] [Related]
6. Generation and characterization of induced pluripotent stem cell line IITGi001-A derived from adult human primary dermal fibroblasts.
Raina K; Joshi G; Modak K; Premkumar C; Priyanka S; Rajesh P; Velayudhan SR; Thummer RP
Stem Cell Res; 2023 Sep; 71():103159. PubMed ID: 37392703
[TBL] [Abstract][Full Text] [Related]
7. Generation of an integration-free induced pluripotent stem cell line (CSC-43) from a patient with sporadic Parkinson's disease.
Marote A; Pomeshchik Y; Goldwurm S; Collin A; Lamas NJ; Pinto L; Salgado AJ; Roybon L
Stem Cell Res; 2018 Mar; 27():82-85. PubMed ID: 29334630
[TBL] [Abstract][Full Text] [Related]
8. Generation of an induced pluripotent stem cell line (ZZUi020-A) from a patient with Parkinson's disease harboring the intermediate-length GGC repeat expansions in the NOTCH2NLC gene.
Fan Y; Liu F; Fan LY; Mao CY; Liu H; Zhang C; Yuan YP; Yang J; Wang YL; Liu YT; Shi CH; Xu YM
Stem Cell Res; 2021 Apr; 52():102257. PubMed ID: 33626493
[TBL] [Abstract][Full Text] [Related]
9. Generation of an induced pluripotent stem cell line (CSC-46) from a patient with Parkinson's disease carrying a novel p.R301C mutation in the GBA gene.
Gustavsson N; Marote A; Pomeshchik Y; Russ K; Azevedo C; Chumarina M; Goldwurm S; Collin A; Pinto L; Salgado AJ; Klementieva O; Roybon L; Savchenko E
Stem Cell Res; 2019 Jan; 34():101373. PubMed ID: 30640063
[TBL] [Abstract][Full Text] [Related]
10. Generation of an induced pluripotent stem cell line (CSC-41) from a Parkinson's disease patient carrying a p.G2019S mutation in the LRRK2 gene.
Marote A; Pomeshchik Y; Collin A; Goldwurm S; Lamas NJ; Pinto L; Salgado AJ; Roybon L
Stem Cell Res; 2018 Apr; 28():44-47. PubMed ID: 29414418
[TBL] [Abstract][Full Text] [Related]
11. Generation of an induced pluripotent stem cell line (CSC-32) from a patient with Parkinson's disease carrying a heterozygous variation p.A53T in the SNCA gene.
Azevedo C; Chumarina M; Serafimova E; Goldwurm S; Collin A; Roybon L; Savchenko E; Pomeshchik Y
Stem Cell Res; 2020 Mar; 43():101694. PubMed ID: 31954327
[TBL] [Abstract][Full Text] [Related]
12. Generation of a human induced pluripotent stem cell line (CSC-42) from a patient with sporadic form of Parkinson's disease.
Savchenko E; Marote A; Russ K; Collin A; Goldwurm S; Roybon L; Pomeshchik Y
Stem Cell Res; 2018 Mar; 27():78-81. PubMed ID: 29334629
[TBL] [Abstract][Full Text] [Related]
13. Generation of an induced pluripotent stem cell line (EURACi014-A) from a Parkinson's disease patient with an A53T mutation in the SNCA gene by an integration-free reprogramming method.
Gilmozzi V; Gentile G; Riekschnitz DA; Volpato CB; Di Segni M; Silipigni R; Pramstaller PP; Hicks AA; Pichler I; Zanon A
Stem Cell Res; 2022 Apr; 60():102713. PubMed ID: 35189566
[TBL] [Abstract][Full Text] [Related]
14. Generation of induced pluripotent stem cell line (ZZUi0016-A) from dermal fibroblasts of a normal human.
Gao Y; Wang Y; Wang Z; Sun H; Zhang R; Yang J; Liu Y; Liu H; Zhang Q; Zhang S; Shi C; Xu Y; Song B
Stem Cell Res; 2020 Mar; 43():101717. PubMed ID: 32007761
[TBL] [Abstract][Full Text] [Related]
15. Human induced pluripotent stem cell line from fibroblasts (HEBHMUi015-A) and chondrogenic differentiation.
Zhang Y; Liu Y; Yan W; Zhang X; Hou Y; Zhou Z; Guo R; Liu G; Ma J
Stem Cell Res; 2023 Oct; 72():103201. PubMed ID: 37856927
[TBL] [Abstract][Full Text] [Related]
16. Establishment of human induced pluripotent stem cell line MUi028-A from normal fetal skin fibroblasts.
Chumchuen S; Satirapod C; Tangprasittipap A; Hongeng S
Stem Cell Res; 2022 Apr; 60():102675. PubMed ID: 35114587
[TBL] [Abstract][Full Text] [Related]
17. Establishment of an induced pluripotent stem cell line ZZUi003-A from a 65-year-old male with sporadic Parkinson's disease.
Zheng X; Zhu Z; Chen K; Guo S; Liu T; Liu H
Stem Cell Res; 2017 Aug; 23():119-121. PubMed ID: 28925360
[TBL] [Abstract][Full Text] [Related]
18. Derivation of an induced pluripotent stem cell line (MUSIi004-A) from dermal fibroblasts of a 48-year-old spinocerebellar ataxia type 3 patient.
Ritthaphai A; Wattanapanitch M; Pithukpakorn M; Heepchantree W; Soi-Ampornkul R; Mahaisavariya P; Triwongwaranat D; Pattanapanyasat K; Vatanashevanopakorn C
Stem Cell Res; 2018 Jul; 30():113-116. PubMed ID: 29852467
[TBL] [Abstract][Full Text] [Related]
19. Generation of iPSC line from a Parkinson patient with PARK7 mutation and CRISPR-edited Gibco human episomal iPSC line to mimic PARK7 mutation.
Mazza MC; Beilina A; Roosen DA; Hauser D; Cookson MR
Stem Cell Res; 2021 Aug; 55():102506. PubMed ID: 34419745
[TBL] [Abstract][Full Text] [Related]
20. Generation of an induced pluripotent stem cell line, FJMUUHi001-A, from a hereditary Parkinson's disease patient with homozygous mutation of c.189dupA in PARK7.
Chen ZT; Zhao ZH; Chen LN; Fan F; Cai GE; Weng HD; Wang YQ; Liao LM; Chen XC; Huang E; Ye QY
Stem Cell Res; 2021 Mar; 51():102175. PubMed ID: 33485186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
